Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.306 USD | +1.24% | +1.56% | -13.33% |
May. 08 | Transcript : Immunic, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
May. 08 | Immunic, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.33% | 116M | |
+8.88% | 115B | |
+13.17% | 107B | |
-13.82% | 22.31B | |
-4.05% | 21.6B | |
-5.69% | 18.23B | |
-38.57% | 17.62B | |
+7.46% | 14.26B | |
+34.42% | 12.37B | |
-27.56% | 8.28B |
- Stock Market
- Equities
- IMUX Stock
- News Immunic, Inc.
- Wedbush Adjusts Immunic's Price Target to $14 From $61, Removing IMU-838/Ulcerative Colitis From Model; Outperform Rating Kept